ReeLabs

ReeLabs is an India-based private healthcare and regenerative medicine company focused on stem cell banking, stem cell processing, and cell-based therapeutic applications. The company markets itself as India’s first integrated stem cell company, combining biobanking services with research and therapy development, and it offers storage from up to 10 biological sources including cord blood, cord tissue, placenta, amniotic sac, and amniotic fluid. ReeLabs also highlights proprietary technologies, patents, publications, and multiple clinical trials in regenerative medicine and cell therapy. Its activities span family stem cell banking, translational research, and investigational treatment programs for hematologic, degenerative, vascular, infectious, and aesthetic indications. The company appears to be commercial-stage as a service provider rather than a traditional drug-development biotech with a clearly disclosed product-by-product therapeutic pipeline.